Assert-IQ vs Bunkerhill AVC

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott Medical

Bunkerhill AVC

by BunkerHill Health

AI Verdict

Tool A, Assert-IQ, specializes in long-term, insertable cardiac monitoring for comprehensive arrhythmia detection through continuous rhythm analysis. In contrast, Tool B, Bunkerhill AVC, uses generative AI to analyze imaging data for automated detection and quantification of various cardiovascular calcifications and opportunistic bone density assessment, integrating with EHRs for broader clinical reasoning. While both provide AI-driven clinical decision support within cardiology, they address different specific clinical problems and utilize distinct data sources.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous, and remote cardiac monitoring for comprehensive arrhythmia detection. This tool is ideal for identifying elusive or infrequent arrhythmias over several years, providing proactive alerts and patient-activated symptom logging to support timely clinical intervention.

View Assert-IQ →

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if you require advanced generative AI for automated quantification of cardiovascular calcifications and opportunistic bone density assessment directly integrated into your EHR system. This solution is best suited for health systems aiming to enhance clinical reasoning and action by leveraging AI to analyze imaging data for early detection and risk stratification.

View Bunkerhill AVC →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Bunkerhill AVC
Pricing	Enterprise	Contact for pricing
Deployment	Hybrid	Integrates with full Electronic Health Records (EHRs) and clinical archives within health systems.
FDA Status	Cleared AI-estimated	1 AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill AVC

Tool B's deployment integrates with full Electronic Health Records (EHRs) and clinical archives, and it features natural language processing for patient record interaction, suggesting a streamlined clinician workflow. Tool A lacks a mobile app and API, which could limit its overall accessibility and integration for some users.

Clinical Value

Bunkerhill AVC

Tool B leverages Generative AI for clinical reasoning and action, offering automated detection and quantification across multiple calcification types and opportunistic bone density assessment. Tool A focuses on long-term continuous cardiac monitoring and advanced arrhythmia detection, which is valuable but narrower in scope compared to Tool B's diverse diagnostic insights.

Pricing & Value

Tie

Both tools require direct contact for institutional pricing and neither offers a free trial. Without specific pricing details for either, it is impossible to compare their value propositions based on cost.

Enterprise Readiness

Bunkerhill AVC

Tool B explicitly states integration with full Electronic Health Records (EHRs) and clinical archives within health systems, and offers customizable AI agents for diverse workflows. It also confirms a Business Associate Agreement (BAA), indicating robust adaptability and compliance for enterprise deployments.

Innovation

Bunkerhill AVC

Tool B's use of Generative AI for clinical reasoning and action, along with natural language processing for patient record interaction, represents a more advanced and broader application of AI. Tool A's innovation is focused on long-term continuous cardiac monitoring and advanced arrhythmia detection algorithms.

Support & Docs

Tie

The provided JSON data for both tools does not contain any information regarding support channels, documentation, or language availability beyond English for Tool A. Therefore, a comparison of support and documentation is not possible.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Bunkerhill AVC
Name	Assert-IQ	Bunkerhill AVC
Company	Abbott Medical	BunkerHill Health
Description	The Assert-IQu2122 Insertable Cardiac Monitor (ICM) system provides long-term, continuous monitoring and advanced arrhythmia detection to aid physicians in diagnosing and managing patients with suspected heart rhythm disorders.	Bunkerhill Health provides a generative AI platform, Carebricks, for clinical reasoning and action, integrating with EHRs to automate workflows and improve patient outcomes. Its FDA-cleared algorithm, Bunkerhill AVC, specifically aids in the early detection and quantification of aortic valve calcification from chest CTs.
Key Features	Long-term continuous cardiac monitoring (up to 6 years), Advanced arrhythmia detection algorithms, Bluetoothu00ae Low Energy data transmission, Secure cloud-based data platform, Remote monitoring capabilities, Proactive clinician alerts, Patient activator for symptom logging, Minimally invasive insertion	Generative AI for clinical reasoning and action, Automated detection and quantification of aortic valve calcification (Bunkerhill AVC), Automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC), Automated detection and quantification of mitral annular calcification (Bunkerhill MAC), Opportunistic bone density assessment (Bunkerhill BMD), Integration with Electronic Health Records (EHRs) and clinical archives, Customizable AI agents for diverse workflows, Natural language processing for patient record interaction (Carebricks Chat)
Specialties	Cardiology, Internal Medicine	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Bunkerhill AVC.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of Assert-IQ versus Bunkerhill AVC?

Assert-IQ is an insertable cardiac monitor system designed for long-term, continuous monitoring and advanced arrhythmia detection to diagnose and manage patients with suspected heart rhythm disorders. In contrast, Bunkerhill AVC is an FDA-cleared algorithm on a generative AI platform that specifically aids in the early detection and quantification of aortic valve calcification from chest CTs, along with other calcifications like coronary artery and mitral annular calcification, and opportunistic bone density assessment.

How do Assert-IQ and Bunkerhill AVC integrate into a healthcare system's infrastructure?

Assert-IQ uses a hybrid deployment model with remote monitoring capabilities and a secure cloud-based data platform for data transmission. Bunkerhill AVC integrates directly with full Electronic Health Records (EHRs) and clinical archives within health systems, and its AI platform, Carebricks, allows for customizable AI agents and workflows.

What types of patient data do these tools process to generate their insights?

Assert-IQ collects continuous cardiac rhythm data from its insertable cardiac monitor, checking heart rhythms every 20 seconds. Bunkerhill AVC analyzes non-gated, non-contrast chest CT scans to detect and quantify calcifications, and its Carebricks platform can reason across a patient's full medical history using EHR data.

What is the maximum duration of continuous monitoring offered by Assert-IQ, and does Bunkerhill AVC offer a similar long-term monitoring capability?

Assert-IQ provides long-term continuous cardiac monitoring for up to 6 years, with options for at least three or six years of battery life. Bunkerhill AVC focuses on automated analysis of existing imaging data from chest CTs and integration with EHRs for clinical reasoning, rather than continuous patient-device monitoring over a specified long duration.

Beyond their core functions, what unique advanced features does each tool provide?

Assert-IQ offers advanced arrhythmia detection algorithms, Bluetooth Low Energy data transmission, proactive clinician alerts, a patient activator for symptom logging, and remote programmability. Bunkerhill AVC's platform includes generative AI for clinical reasoning, automated detection and quantification of various calcifications (coronary artery, mitral annular), opportunistic bone density assessment, customizable AI agents for diverse workflows, and natural language processing for patient record interaction (Carebricks Chat).